Plasma phospholipid EPA and DHA in relation to atherosclerosis in 61-year-old men

Atherosclerosis

Volumn 205, Issue 2, 2009, Pages 574-578

  Lindqvist, Helen M ^a   Sandberg, Ann Sofie ^a   Fagerberg, Björn ^b   Hulthe, Johannes ^b  

^a CHALMERS UNIVERSITY OF TECHNOLOGY   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Atherosclerosis; EPA; Inter media thickness; n 3 Fatty acid

Indexed keywords

CELL ADHESION MOLECULE; DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; LIPID; PHOSPHOLIPID;

ADULT; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BLOOD PRESSURE MEASUREMENT; CAROTID ARTERY OBSTRUCTION; CIGARETTE SMOKING; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE MARKER; ECHOGRAPHY; FEMORAL ARTERY; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PHOSPHOLIPID BLOOD LEVEL; PRIORITY JOURNAL; SOCIOECONOMICS; SYSTOLIC BLOOD PRESSURE; VASCULAR ENDOTHELIUM;

ATHEROSCLEROSIS; CARDIOVASCULAR DISEASES; CAROTID ARTERIES; DISEASE PROGRESSION; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; FEMORAL ARTERY; HUMANS; MALE; MIDDLE AGED; PHOSPHOLIPIDS; RISK FACTORS; SMOKING; TUNICA INTIMA; TUNICA MEDIA;

EID: 67650928344     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2008.12.032     Document Type: Article

References (35)

1. Konig A., Bouzan C., Cohen J.T., et al. A quantitative analysis of fish consumption and coronary heart disease mortality. Am J Prev Med 29 (2005) 335-346
2. Psota T.L., Gebauer S.K., and Kris-Etherton P. Dietary omega-3 fatty acid intake and cardiovascular risk. Am J Cardiol 98 (2006) 3i-18i
3. Wang C., Harris W.S., Chung M., et al. n-3 Fatty acids from fish or fish-oil supplements, but not alpha-linolenic acid, benefit cardiovascular disease outcomes in primary- and secondary-prevention studies: a systematic review. Am J Clin Nutr 84 (2006) 5-17
4. Albert C.M., Campos H., Stampfer M.L., et al. Blood levels of long-chain n-3 fatty acids and the risk for sudden death. N Engl J Med 346 (2002) 1113-1118
5. Simon J.A., Hodgkins M.L., Browner W.S., Neuhaus J.M., Bernert Jr. J.T., and Hulley S.B. Serum fatty acids and the risk of coronary heart disease. Am J Epidemiol 142 (1995) 469-476
6. Breslow J.L. n-3 fatty acids and cardiovascular disease. Am J Clin Nutr 83 (2006) 1477S-1482S
7. Hamer M., and Steptoe A. Influence of specific nutrients on progression of atherosclerosis, vascular function, haemostasis and inflammation in coronary heart disease patients: a systematic review. Br J Nutr 95 (2006) 849-859
8. Lorenz M.W., Markus H.S., Bots M.L., Rosvall M., and Sitzer M. Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation 115 (2007) 459-467
9. Balk E.M., Lichtenstein A.H., Chung M., Kupelnick B., Chew P., and Lau J. Effects of omega-3 fatty acids on coronary restenosis, intima-media thickness, and exercise tolerance: a systematic review. Atherosclerosis 184 (2006) 237-246
10. Andersen L.F., Solvoll K., and Drevon C.A. Very-long-chain n-3 fatty acids as biomarkers for intake of fish and n-3 fatty acid concentrates. Am J Clin Nutr 64 (1996) 305-311
11. Hodge A.M., Simpson J.A., Gibson R.A., et al. Plasma phospholipid fatty acid composition as a biomarker of habitual dietary fat intake in an ethnically diverse cohort. Nutr Metab Cardiovasc Dis 17 (2007) 415-426
12. Bokemark L., Wikstrand J., Attvall S., Hulthe J., Wedel H., and Fagerberg B. Insulin resistance and intima-media thickness in the carotid and femoral arteries of clinically healthy 58-year-old men. The Atherosclerosis and Insulin Resistance Study (AIR). J Intern Med 249 (2001) 59-67
13. Wallenfeldt K., Fagerberg B., Wikstrand J., and Hulthe J. Oxidized low-density lipoprotein in plasma is a prognostic marker of subclinical atherosclerosis development in clinically healthy men. J Intern Med 256 (2004) 413-420
14. Lee C.M., Trevino B., and Chaiyawat M. A simple and rapid solvent extraction method for determining total lipids in fish tissue. J AOAC Int 79 (1996) 487-492
15. Kaluzny M.A., Duncan L.A., Merritt M.V., and Epps D.E. Rapid separation of lipid classes in high yield and purity using bonded phase columns. J Lipid Res 26 (1985) 135-140
16. Lindqvist H., Langkilde A.M., Undeland I., Radendal T., Sandberg A.S., and Herring. (Clupea harengus) supplemented diet influences risk factors for CVD in overweight subjects. Eur J Clin Nutr 61 (2007) 1106-1113
17. Wendelhag I., Wiklund O., and Wikstrand J. Atherosclerotic changes in the femoral and carotid arteries in familial hypercholesterolemia. Ultrasonographic assessment of intima-media thickness and plaque occurrence. Arterioscler Thromb 13 (1993) 1404-1411
18. Wendelhag I., Liang Q., Gustavsson T., and Wikstrand J. A new automated computerized analyzing system simplifies readings and reduces the variability in ultrasound measurement of intima-media thickness. Stroke 28 (1997) 2195-2200
19. Schmidt C., and Wendelhag I. How can the variability in ultrasound measurement of intima-media thickness be reduced? Studies of interobserver variability in carotid and femoral arteries. Clin Physiol 19 (1999) 45-55
20. Wendelhag I., Wiklund O., and Wikstrand J. On quantifying plaque size and intima-media thickness in carotid and femoral arteries. Comments on results from a prospective ultrasound study in patients with familial hypercholesterolemia. Arterioscler Thromb Vasc Biol 16 (1996) 843-850
21. Hulthe J., Wikstrand J., and Fagerberg B. Relationship between C-reactive protein and intima-media thickness in the carotid and femoral arteries and to antibodies against oxidized low-density lipoprotein in healthy men: the Atherosclerosis and Insulin Resistance (AIR) study. Clin Sci (Lond) 100 (2001) 371-378
22. Hino A., Adachi H., Toyomasu K., et al. Very long chain N-3 fatty acids intake and carotid atherosclerosis: an epidemiological study evaluated by ultrasonography. Atherosclerosis 176 (2004) 145-149
23. Ebbesson S.O., Roman M.J., Devereux R.B., et al. Consumption of omega-3 fatty acids is not associated with a reduction in carotid atherosclerosis: The Genetics of Coronary Artery Disease in Alaska Natives study. Atherosclerosis 3 (2007) 3
24. Mita T., Watada H., Ogihara T., et al. Eicosapentaenoic acid reduces the progression of carotid intima-media thickness in patients with type 2 diabetes. Atherosclerosis 191 (2007) 162-167
25. Yamada T., Strong J.P., Ishii T., et al. Atherosclerosis and omega-3 fatty acids in the populations of a fishing village and a farming village in Japan. Atherosclerosis 153 (2000) 469-481
26. Hjerkinn E.M., Abdelnoor M., Breivik L., et al. Effect of diet or very long chain omega-3 fatty acids on progression of atherosclerosis, evaluated by carotid plaques, intima-media thickness and by pulse wave propagation in elderly men with hypercholesterolaemia. Eur J Cardiovasc Prev Rehabil 13 (2006) 325-333
27. Armentano R.L., Graf S., Barra J.G., et al. Carotid wall viscosity increase is related to intima-media thickening in hypertensive patients. Hypertension 31 (1998) 534-539
28. Pakala R., Pakala R., and Benedict C. Eicosapentaenoic acid and docosahexaenoic acid selectively attenuate U46619-induced smooth muscle cell proliferation. Lipids 34 (1999) 915-920
29. von Schacky C. n-3 PUFA in CVD: influence of cytokine polymorphism. Proc Nutr Soc 66 (2007) 166-170
30. De Caterina R., Liao J.K., and Libby P. Fatty acid modulation of endothelial activation. Am J Clin Nutr 71 (2000) 213S-223S
31. Hooper L., Thompson R.L., Harrison R.A., et al. Risks and benefits of omega 3 fats for mortality, cardiovascular disease, and cancer: systematic review. BMJ 332 (2006) 752-760
32. Tierney A.C., and Roche H.M. The potential role of olive oil-derived MUFA in insulin sensitivity. Mol Nutr Food Res 51 (2007) 1235-1248
33. Mori T.A. Omega-3 fatty acids and hypertension in humans. Clin Exp Pharmacol Physiol 33 (2006) 842-846
34. Hermansen K. Diet, blood pressure and hypertension. Br J Nutr 83 Suppl. 1 (2000) S113-S119
35. Hibbeln J.R., Makino K.K., Martin C.E., Dickerson F., Boronow J., and Fenton W.S. Smoking, gender, and dietary influences on erythrocyte essential fatty acid composition among patients with schizophrenia or schizoaffective disorder. Biol Psychiatry 53 (2003) 431-441